According to Democratic Gov. John Hickenlooper, around 70 percent of pregnancies in the state are unintended.
Naysayers would have us believe that Texans have surrendered to the inevitable, that they have stopped working for reproductive rights after the fervor of the summer of 2013. Nothing I have seen in the last year suggests that they are any less angry, any less passionate, than they were last June.
After winning a settlement that opened the door for thousands of women to initiate malpractice lawsuits against Dalkon Shield, the IUD that caused my sterilization, I naively thought we had seen the end of sterilization atrocities. Unfortunately, that is not so, at least in California.
Gates and others have long claimed that conversations about abortion are “toxic” not just to feminism and the equality movement, but political progress in general. To that I say hooey.
Modern Mississippi freedom fighters must remain committed to Hamer’s legacy of bridging voting and reproductive rights into a comprehensive reproductive justice effort to protect Black women and other populations that are vulnerable to violations of both.
The willingness of courts to impose the kind of restrictions at issue in this case should raise some serious concerns for reproductive rights activists.
California’s Maximum Family Grant rule denies financial support to babies born while their families are receiving grants from the state’s welfare program. An effort is underway to repeal the rule and to deconstruct the narrative that poor women have babies for money.
A lawsuit filed by a New York woman against a local hospital alleges that she was forced to undergo a c-section
against her will. The suit is believed to be the first to raise a claim under a New York public health law detailing the rights of patients at hospitals in the state, but experts worry that such cases could become more common.
Gov. Paul LePage vetoed a bill that would have expanded Medicaid coverage of family planning services for nearly 14,000 low-income women, and a vote to override the veto failed.
Though the FDA decision to permit generic EC pill manufacturers to sell their products over the counter represents a gain for those with the most access to resources, ultimately the decision reflects pharmaceutical manufacturing companies’ interests, rather than the lives of those most adversely affected by lack of access to EC.